BAT-backed CBD treatment for autism gets FDA greenlight for next round of trials
The U.S. Food and Drug Administration (FDA) has authorized Phase 2 clinical trials for an oral CBD solution intended to address autism spectrum disorder (ASD). The initiative to develop the
BAT-backed CBD treatment for autism gets FDA greenlight for next round of trials Read More »










